DK143183C - Analogifremgangsmaade til fremstilling af 1h-pyrazolo(3,4-b)pyridiner eller fysiologisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 1h-pyrazolo(3,4-b)pyridiner eller fysiologisk acceptable salte deraf

Info

Publication number
DK143183C
DK143183C DK428477A DK428477A DK143183C DK 143183 C DK143183 C DK 143183C DK 428477 A DK428477 A DK 428477A DK 428477 A DK428477 A DK 428477A DK 143183 C DK143183 C DK 143183C
Authority
DK
Denmark
Prior art keywords
pyrazolo
pyridines
analogue
preparation
acceptable salts
Prior art date
Application number
DK428477A
Other languages
English (en)
Other versions
DK428477A (da
DK143183B (da
Inventor
J Roch
E Mueller
B Narr
J Nickl
W Haarmann
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK428477A publication Critical patent/DK428477A/da
Publication of DK143183B publication Critical patent/DK143183B/da
Application granted granted Critical
Publication of DK143183C publication Critical patent/DK143183C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK428477A 1976-09-29 1977-09-28 Analogifremgangsmaade til fremstilling af 1h-pyrazolo(3,4-b)pyridiner eller fysiologisk acceptable salte deraf DK143183C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762643753 DE2643753A1 (de) 1976-09-29 1976-09-29 Neue 1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine
DE2643753 1976-09-29

Publications (3)

Publication Number Publication Date
DK428477A DK428477A (da) 1978-03-30
DK143183B DK143183B (da) 1981-07-13
DK143183C true DK143183C (da) 1981-11-16

Family

ID=5989097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK428477A DK143183C (da) 1976-09-29 1977-09-28 Analogifremgangsmaade til fremstilling af 1h-pyrazolo(3,4-b)pyridiner eller fysiologisk acceptable salte deraf

Country Status (21)

Country Link
US (3) US4182887A (da)
JP (1) JPS5344588A (da)
AT (1) AT359064B (da)
AU (1) AU513406B2 (da)
BE (1) BE859152A (da)
DE (1) DE2643753A1 (da)
DK (1) DK143183C (da)
ES (1) ES462700A1 (da)
FI (1) FI61899C (da)
FR (1) FR2366290A1 (da)
GB (1) GB1552730A (da)
GR (1) GR64049B (da)
IE (1) IE45700B1 (da)
IL (1) IL52997A (da)
LU (1) LU78179A1 (da)
NL (1) NL7710573A (da)
NO (1) NO147913C (da)
NZ (1) NZ185292A (da)
PT (1) PT67091B (da)
SE (1) SE7710873L (da)
ZA (1) ZA775784B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2643753A1 (de) * 1976-09-29 1978-04-06 Thomae Gmbh Dr K Neue 1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine
AR037233A1 (es) * 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
CA2531619A1 (en) * 2003-07-16 2005-01-27 Neurogen Corporation Biaryl piperazinyl-pyridine analogues
US7338951B2 (en) 2003-11-10 2008-03-04 Synta Pharmaceuticals Corp. Pyridine compounds
CN1984891B (zh) * 2004-07-06 2012-08-08 弗·哈夫曼-拉罗切有限公司 用作合成nk-1受体拮抗剂的中间体的甲酰胺吡啶衍生物的制备方法
KR100881240B1 (ko) 2004-07-06 2009-02-05 에프. 호프만-라 로슈 아게 Nk-1 수용체 길항제의 합성에 있어서 중간체로서사용되는 카르복스아미드 피리딘 유도체의 제조 방법
MY145822A (en) * 2004-08-13 2012-04-30 Neurogen Corp Substituted biaryl piperazinyl-pyridine analogues
WO2006050109A2 (en) * 2004-10-29 2006-05-11 Abbott Laboratories Novel kinase inhibitors
DE102004061288A1 (de) * 2004-12-14 2006-06-29 Schering Ag 3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
US7725056B2 (en) * 2006-01-10 2010-05-25 Ricoh Co., Ltd. Triboelectric charging device and field assisted toner transporter
MY156814A (en) * 2007-03-15 2016-03-31 Novartis Ag Organic compounds and their uses
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
ES2392488T3 (es) 2008-11-20 2012-12-11 Genentech, Inc. Compuestos inhibidores de PI3K de tipo pirazolopiridina y sus procedimientos de uso
EP2464647B1 (en) 2009-08-11 2016-09-21 Bristol-Myers Squibb Company Azaindazoles as btk kinase modulators and use thereof
US20220259199A1 (en) * 2018-05-02 2022-08-18 Jw Pharmaceutical Corporation Novel heterocycle derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2232038A1 (de) * 1972-06-30 1974-01-10 Hoechst Ag 3-amino-1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine, ihre herstellung und verwendung
DE2643753A1 (de) * 1976-09-29 1978-04-06 Thomae Gmbh Dr K Neue 1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine
US4048184A (en) * 1976-11-15 1977-09-13 E. R. Squibb & Sons, Inc. 6-Phenyl-2H-pyrazolo[3,4-b]pyridines

Also Published As

Publication number Publication date
DE2643753A1 (de) 1978-04-06
GR64049B (en) 1980-01-19
NZ185292A (en) 1980-05-08
LU78179A1 (da) 1978-11-03
AU513406B2 (en) 1980-11-27
DK428477A (da) 1978-03-30
IE45700B1 (en) 1982-11-03
FR2366290B1 (da) 1982-07-09
US4224322A (en) 1980-09-23
ZA775784B (en) 1979-06-27
GB1552730A (en) 1979-09-19
NL7710573A (nl) 1978-03-31
DK143183B (da) 1981-07-13
PT67091B (de) 1979-09-12
NO147913C (no) 1983-07-06
PT67091A (de) 1977-10-01
FR2366290A1 (fr) 1978-04-28
SE7710873L (sv) 1978-03-30
IL52997A (en) 1980-09-16
AT359064B (de) 1980-10-27
NO147913B (no) 1983-03-28
IL52997A0 (en) 1977-11-30
ATA670077A (de) 1980-03-15
US4260621A (en) 1981-04-07
US4182887A (en) 1980-01-08
JPS5344588A (en) 1978-04-21
BE859152A (fr) 1978-03-28
NO773327L (no) 1978-03-30
FI61899C (fi) 1982-10-11
FI772655A (fi) 1978-03-30
AU2903777A (en) 1979-03-29
ES462700A1 (es) 1978-06-01
FI61899B (fi) 1982-06-30
IE45700L (en) 1978-03-29

Similar Documents

Publication Publication Date Title
DK163244C (da) Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf
DK152753C (da) Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-3,4,5-trihydroxypiperidinderivater eller farmaceutisk acceptable salte eller stereoisomere deraf
DK150512C (da) Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
DK138281A (da) Fremgangsmaade til fremstilling af 3-(1-piperidinylalkyl)-4h-pyrido (1,2-a) pyrimidin-4-on-derivater
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK143183C (da) Analogifremgangsmaade til fremstilling af 1h-pyrazolo(3,4-b)pyridiner eller fysiologisk acceptable salte deraf
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK405477A (da) Fremgangsmaade til fremstilling af 5-alkoxyimidazo(1,2-a) quinolin-2-carboxylsyrer eller estere eller kationiske salte deraf
DK148233C (da) Analogifremgangsmaade til fremstilling af 5,11-dihydro-6h-pyrido-(2,3-b)(1,4)benzodiazepin-6-oner, der er substitueret i 11-stillingen, eller salte deraf
DK157022C (da) Analogifremgangsmaade til fremstilling af 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido oe1,2-aaapyrimidinderivater eller farmaceutisk acceptable salte, hydrater, stereoisomere, optisk aktive isomere, geometriske isomere og tautomere deraf
DK149856C (da) Fremgangsmaade til fremstilling af 1,3-di- eller 1,3,8-trisubstituerede xanthiner eller fysiologisk acceptable salte deraf
DK154430C (da) Analogifremgangsmaade til fremstilling af indolo(2,3-a)quinolizidiner eller syreadditionssalte heraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK164379A (da) Fremgangsmaade til fremstilling af 7-methoxy-5-oxo-5h-thiazolo(2,3-b)quinazolin-2-carboxylsyre eller farmaceutisk anvendelige salte deraf
DK273776A (da) Fremgangsmade til fremstilling af 2,4-dioxo-1,2,3,4-tetrahydro-s-triazino-(1,2-a)-benzimidazoler
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK148176A (da) Fremgangsmade til fremstilling af 9h-pyrido(3,4-b)indolderivater eller deres salte
DK277682A (da) Fremgangsmaade til fremstilling af substituerede imidazo (1,5-a)pyridiner eller salte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK143703C (da) Analogifremgangsmaade til fremstilling af 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de)=(1,5)naphthyridin-derivater eller syreadditionssalte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK143403C (da) Analogifremgangsmaade til fremstilling af 8-(1h-tetrazol-5-yl)-11h-pyrido(2,1-b)quinazolin-11-oner eller salte deraf